Neonatal lupus: Bedside to bench and back

Scandinavian Journal of Rheumatology

Volumn 25, Issue 5, 1996, Pages 271-276

  Buyon, J P ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Anti SSA Ro antibodies; Anti SSB La antibodies; Congenital heart block; Neonatal lupus

Indexed keywords

AUTOANTIBODY; DEXAMETHASONE;

CONGENITAL HEART BLOCK; HUMAN; LUPUS ERYTHEMATOSUS; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0029905247     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609104057     Document Type: Review

References (49)

1. Morquio L. Sur une maladie infantile et familiale characterisee par des modifications permanentes du pouls, des attaques syncopales et epileptiformes et al. mort subite. Arch Med Inf 1901; 4: 467-75.
2. Aylward RD. Congenital heart-block. Br Med J 1928; 943.
3. McCue CM, Mantakas ME, Tingelstad JB. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977; 56: 82-90.
4. Chameides L, Truex RC, Vetter V, Rashkind WJ, Galioto FM, Noonan JA. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 1977; 297: 1204-7.
5. Winkler RB, Nora AH, Nora JJ. Familial congenital complete heart block and maternal systemic lupus erythematosus. Circulation 1977; 56: 1103-7.
6. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983; 309: 209-12.
7. Lee LA, Reed BR, Harmon C. Autoantibodies to SS-A/Ro in congenital heart block. Arth Rheum 1983; 20: S24.
8. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Annals Int Med 1994; 120: 544-51.
9. Julkunen H, Kurki P, Kaaja R, Heikkila R, Ilkka I, Chan EKL, Wallgren E, Friman C. Isolated congenital heart block: long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993; 36: 1588-98.
10. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Long-term outcome of mothers of children with complete congenital heart block. Am J Med 1996; 100: 328-32.
11. Buyon JP. Neonatal lupus syndromes. In: Lahita R, ed. Systemic Lupus Erythematosus. New York; Churchill Livingstone 1992: 419-35.
12. Lee LA. Neonatal lupus erythematosus. J Invest Derm 1993; 100: 9s-13s.
13. McCuistion CH, Schoch EP. Possible discoid lupus erythematosus in a newborn infant. Report of a case with subsequent development of acute systemic lupus erythematosus in the mother. Arch Dermatol Syph 1954; 70: 782-5.
14. Kephardt DC, Hood AF, Provost TT. Neonatal lupus erythematosus: new serologic findings. J Invest Derm 1987; 77: 331-3.
15. Ben-Chetrit E, Gandy BJ, Tan EM, Sullivan KF. Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. J Clin Invest 1989; 83: 1284-92.
16. Deutscher SL, Harley JB, Keene JD. Molecular analysis of the 60 kDa human Ro ribonucleoprotein. Proc Natl Acad Sci USA 1988; 85: 9479-93.
17. Lerner MR, Boyle JA, Hardin JA, Steitz JA. Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 1981; 211: 400-2.
18. O'Brien CA, Wolin SL. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5s rRNA precursors. Genes and Development 1994; 8: 2891-903.
19. Chan EKL, Hamel JC, Buyon JP, Tan EM. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 1991; 87: 68-76.
20. Itoh K, Itoh Y, Frank MB. Protein heterogeneity in the human Ro/SSA ribonucleoproteins. J Clin Invest 1991; 87: 177-86.
21. Chan EKL, Francour AM, Tan EM. Epitopes, structural domains and asymmetry of amino acid residues in SS-B/La nuclear protein. J Immunol 1986; 136: 3744-9.
22. Chambers JC, Kenan D, Martin BJ, Keene JD. Genomic structure and amino acid sequence domains of the human La autoantigen. J Biol Chem 1988; 263: 18043-51.
23. Gottlieb E, Steitz JA. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J 1989; 8: 851-61.
24. Boire G, Craft J. Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J Clin Invest 1990; 85: 1182-90.
25. Chan EKL, DiDonato F, Hamel JC, Tseng CE, Buyon JP. 52-kD SS-A/Ro: Genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipperminus autoantigen expressed in fetal and adult heart. J Exp Med 1995; 182: 983-92.
26. Buyon JP, Tseng C, DiDonato F, Rashbaum W, Hamel JC, Chan EKL. Increased fetal expression of a novel alternative 52RomRNA transcript, 52B, coincides with vulnerability for congenital heart block (CHB). Clin Res, 1996 (Abstract) (in press).
27. Stiehm ER. Fetal defense mechanisms. Am J Dis Child 1975; 129: 438-42.
28. Horsfall AC, Venables PJW, Taylor PV, Maini RN. Ro and La antigens and maternal autoantibody idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991; 4: 165-76.
29. Reichlin M, Brucato A, Frank MB, Maddison PJ, McCubbin, Wolfson-Reichlin M, Lee Lela. Concentration of autoantibodies to native 60-kD Ro/SS-A and denatured 52-kD Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arth Rheum 1994; 37: 1698-703.
30. Alexander E, Buyon JP, Provost TT, Guarnieri T. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model: in vitro electrophysiologic and immunocytochemical studies. Arth Rheum 1992; 35: 176-89.
31. Garcia S, Nascimento JHM, Bonfa E, Levy R, Oliveira SF, Tavares AV, Campos deCarvalho AC. Cellular mechanism of the conduction abnormalities induced by serum from antiRo/SSA-positive patients in rabbit hearts. J Clin Invest 1994; 93: 718-24.
32. ca). Arth Rheum 1995; 38: S230.
33. + currents in fetal, neonatal and adult rabbit ventricular myocytes. Circ Res 1992; 70: 508-15.
34. Maylie JG. Excitation-contraction coupling in neonatal and adult myocardium of cat. Am J Physiol 1982; 242: H834-43.
35. Frohn-Mulder I, Meilof JF, Szatmari A, Stewart PA, Swaak TJ, Hess J. Clinical significance of maternal antiRo/SS-A antibodies in children with isolated heart block. J Am Coll Cardiol 1994; 23: 1677-81.
36. Hubscher O, Batista N, Rivero S, Marietta C, Arriagada M, Boire G, Menard HA, Arana RM. Clinical and serological identification of 2 forms of complete heart block in children. J Rheumatol 1995; 22: 1352-5.
37. Meilof JF, Frohn-Mulder IME, Stewart PA, Szatmari A, Hess J, Veldhoven CHA, Smeenk RJT, Swaak AJG. Maternal autoantibodies and congenital heart block: No evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile. Lupus 1993; 2: 239-46.
38. Buyon JP, Winchester RJ, Slade SG. Arnett F, Copel J, Friedman D, Lockshin MD. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Arthritis Rheum 1993; 36: 1263-73.
39. Ben-Chetrit E, Fox RI, Tan EM. Dissociation of immune responses to the SS-A/Ro 52-kD and 60-kD polypeptides in systemic lupus erythematosus and Sjogrens syndrome. Arthritis Rheum 1990; 33: 349-55.
40. Itoh Y, Reichlin M. Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992; 14: 57-65.
41. McCune AB, Weston WL, Lee LA. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 1987; 106: 518-23.
42. Schoenlebe J, Buyon JP, Zitelli B, Friedman D, Greco MA, Knisely AS. Neonatal hemochromatosis associated with maternal autoantibodies to Ro/SSA and La/SSB ribonucleoproteins. Am J Dis Child 1993; 147: 1072-5.
43. Lee LA. Maternal autoantibodies and pregnancy-II: the neonatal lupus syndrome. Bailliere's Clinical Rheumatology 1990; 4: 69-84.
44. Silverman ED. Congenital heart block and neonatal lupus erythematosus: prevention is the goal. Children's CME 1993; 20: 1101-4.
45. Julkunen H, Kaaja R, Wallgren E, Teramo K. Isolated congenital heart block: Fetal and infant outcome and familial incidence of heart block. Obstet Gynecol 1993; 82: 11-6.
46. Buyon J, Swersky S, Fox H, Bierman F, Winchester R. Intrauterine therapy of presumptive fetal myocarditis with heart block occurring in a mother with systemic lupus erythematosus and a predominance of La (SSB) antibodies. Arthritis Rheum 1987; 40: 44-9.
47. Rider LG, Buyon JP, Rutledge J, Sherry DD. Treatment of neonatal lupus: Case report and review of the literature. J Rheum 1993; 20: 1208-11.
48. Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ. Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a mother with systemic lupus erythematosus. J Rheum 1993; 20: 1204-7.
49. Copel J, Buyon J, Kleinman C. Successful in utero therapy of fetal heart block. Am J Obstet Gynecol 1995; 173: 1384-90.